Christine C Esau

Summary

Publications

  1. ncbi Inhibition of microRNA with antisense oligonucleotides
    Christine C Esau
    Isis Pharmaceuticals and Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA
    Methods 44:55-60. 2008
  2. ncbi Therapeutic potential for microRNAs
    Christine C Esau
    Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, California 92008, USA
    Adv Drug Deliv Rev 59:101-14. 2007
  3. ncbi MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators
    Galina Gabriely
    Center of Neurologic Diseases, Brigham and Women s Hospital, 4 Blackfan Circle, HIM 758, Boston, MA 02115, USA
    Mol Cell Biol 28:5369-80. 2008

Collaborators

  • Galina Gabriely
  • Anna M Krichevsky
  • Santosh Kesari
  • Julja Burchard
  • Thomas Wurdinger
  • Peter S Linsley

Detail Information

Publications3

  1. ncbi Inhibition of microRNA with antisense oligonucleotides
    Christine C Esau
    Isis Pharmaceuticals and Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA
    Methods 44:55-60. 2008
    ....
  2. ncbi Therapeutic potential for microRNAs
    Christine C Esau
    Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, California 92008, USA
    Adv Drug Deliv Rev 59:101-14. 2007
    ..The next few years should see significant progress in our understanding of miRNA biology and the advancement of the technology for therapeutic modulation of miRNA activity...
  3. ncbi MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators
    Galina Gabriely
    Center of Neurologic Diseases, Brigham and Women s Hospital, 4 Blackfan Circle, HIM 758, Boston, MA 02115, USA
    Mol Cell Biol 28:5369-80. 2008
    ....